FRX - Forest Laboratories Inc.

Forest Laboratories, Inc. (Forest) and its subsidiaries develop, manufacture and sell branded forms of ethical drug products. The Companys United States products are marketed directly, or detailed, to physicians by its salesforces. It also focuses on the development and introduction of new products, including products developed in collaboration with licensing partners. The Companys products include Lexapro, its SSRI for the treatment of major depression in adults and adolescents and GAD in adults; Namenda, its N-methyl-D-aspartate (NMDA) antagonist for the treatment of moderate and severe Alzheimer's disease; Bystolic, its beta-blocker for the treatment of hypertension, and Savella an serotonin and norepinephrine reuptake inhibitor (SNRI) for the management of fibromyalgia. The Companys United Kingdom and Ireland subsidiaries sell both ethical products and over-the-counter preparations. Their products include Sudocrem, Colomycin, Infacol and Exorex.